| |
|
- Former President & CEO of Nexia Biotechnologics Inc. (TSX: NXB)
- At Nexia led Canada’s largest life sciences IPO building and built a team of 135 employees
- Nexia developed products including Protexia®, a medical
countermeasure with broad efficacy against nerve gas agents
- The US government development and sales contract for
Protexia® $215million in 2006
- Professor (tenured) of Molecular Biology – McGill University;
PhD Animal Science (Molecular Genetics) – University of Illinois
- M.Sc. Physiology and Biophysics – U. of I.; M.Sc. Animal
Physiology – McMaster University
- 100 Peer Reviewed Publications, Book Chapters & Abstracts; Inventor With Over 37 US and Foreign Patents
|
|
